Inceptio Technology Joins the Autoware Foundation to Accelerate Autonomous Driving Technologies for Trucks
SHANGHAI, June 18, 2025 /PRNewswire/ -- Inceptio Technology ("Inceptio" or the "Company"), an industry leading developer of autonomous truck technologies, today announced that it has joined the Autoware Foundation, an open alliance for autonomous driving technology. Inceptio will collaborate with the Autoware Foundation members globally to advance innovation and accelerate the deployment of safe, scalable autonomous truck technologies.
Launched in 2018, the Autoware Foundation is a non-profit organization dedicated to supporting open-source collaboration that accelerates the development of autonomous driving technology globally.
Founded in 2018, Inceptio's mission is to build a safer, more efficient line-haul logistics by partnering with OEMs and logistics operators to preload its technologies and systems into series production trucks. Inceptio launched the industry's first series production autonomous trucks in late 2021. To date, Inceptio Autonomous Driving System has achieved over 200 million kilometers of commercial operations.
Inceptio's technology portfolio covers L4, L3 and L2+. Leveraging its proprietary full-stack Inceptio Autonomous Driving System - which features long-range perception, high-precision tractor and tailer control, fuel-efficient driving algorithm, as well as HPC specifically designed for truck's operating condition - Inceptio has delivered proven, significant improvement on safety and saving on fuel and labor to the trucking industry. Its data-driven R&D platform continuously refines core modules in real time, enabling rapid deployment and optimization of its autonomous truck technologies across diverse use cases in trucking.
"We are excited to welcome Inceptio Technology to the Autoware Foundation," said Shinpei Kato, Founder and Fellow of the Autoware Foundation. "Inceptio's proven track record in autonomous trucking and deep industry and production expertise will be invaluable as we work together to build the next generation of autonomous mobility solutions for the trucking industry."
Inceptio will actively participate in the Autoware Foundation initiatives by contributing technology and use cases, exploring new applications, and forging global partnerships. Inceptio will be working with partners including technology companies and leading OEMs to integrate Autoware solutions with its proprietary components in proof-of-concept and series production projects worldwide, in particular in the truck segment.
"We look forward to collaborating with a global open-source community of innovators to accelerate the development of autonomous driving technologies and extend the community's reach deep into truck segment." said Julian Ma, Founder and CEO of Inceptio Technology. "Our extensive experience in series production and insight from world's largest commercial deployment of autonomous truck uniquely position us to contribute to the Autoware Foundation, driving safer and more efficient logistics worldwide."
About the Autoware Foundation
The Autoware Foundation is a non-profit organization that hosts the Autoware project, the world's leading open-source software project for autonomous driving. The Autoware project is built on Robot Operating System (ROS), and through using open source, it lowers the entry barrier to autonomous driving technology and enables commercial deployment of autonomous driving in a broad range of vehicles and applications.
The Autoware Foundation has a vision to build open-source software for globally trusted autonomous driving systems that engage and advance society, and is on a mission to co-create a neutral, trusted hub that advances safety and beyond in mobility and society. Autoware is the trade mark of the Autoware Foundation.
Learn more about the Autoware Foundation on autoware.org
About Inceptio Technology
Inceptio Technology is an industry leading developer of autonomous driving technologies for heavy-duty trucks. Its flagship technology is the Inceptio Autonomous Driving System, a proprietary full-stack solution. Inceptio partnered with leading OEMs to roll out the industry's first series production L3 autonomous trucks in late 2021. These trucks are operated by customers across all line-haul logistics sectors including express delivery, full-truckload (FTL) transportation, less-than-truckload (LTL) transportation, and cold chain. Inceptio is at the cutting edge of developing fully driverless trucks. In 2022 it became the first company in China to receive a public road-testing permit for driverless autonomous heavy-duty trucks.
For more information on Inceptio Technology, visit https://en.inceptio.ai/
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/inceptio-technology-joins-the-autoware-foundation-to-accelerate-autonomous-driving-technologies-for-trucks-302485018.html
SOURCE Inceptio Technology
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?
Novo Nordisk has been actively pursuing licensing deals over the past six months. These have helped the company improve its pipeline in its most important area. There are other good reasons to consider investing in Novo Nordisk right now. 10 stocks we like better than Novo Nordisk › It wasn't so long ago that Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company, seemed to be firing on all cylinders. However, the past year has been challenging for the drugmaker. One reason behind its poor performance over the trailing-12-month period is that it has encountered clinical setbacks. CagriSema, an investigational weight loss medicine, performed well in phase 3 studies, but not quite as well as management had promised. Elsewhere, Novo Nordisk's biggest rival in this area, Eli Lilly, has registered significant clinical wins that arguably put it ahead in this fast-growing market. Still, Novo Nordisk hasn't said its last word yet. The company has recently made significant moves to strengthen its anti-obesity pipeline. Should investors buy the stock following these developments? On June 11, Deep Apple Therapeutics, a privately held biotech company, announced a licensing deal with Novo Nordisk. The former will utilize its proprietary platform, which leverages a virtual library powered by artificial intelligence (AI) to identify promising compounds rapidly. Deep Apple will aim to optimize novel compounds for obesity and other related diseases, and will receive up to $812 million, including an up-front payment and milestones for clinical and regulatory achievements. While it's too early to celebrate this deal -- it's still brand-new and hasn't led to any significant wins yet -- it's worth pointing out that Novo Nordisk has penned several such agreements since the CagriSema setback. One of the more promising of these agreements was with United Biotechnology, a subsidiary of the China-based company United Laboratories International Holdings. Novo Nordisk dished out an up-front payment of $200 million (not to mention potential milestone payments of up to $1.8 billion) to acquire UBT251, a triple agonist -- that is, a medicine that mimics the action of three separate gut hormones: GLP-1, GIP, and glucagon. Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple agonist. So, with this acquisition, Novo Nordisk is trying to catch up to its longtime competitor. This move, along with others, has helped expand Novo Nordisk's weight-management pipeline. Could that help the stock bounce back? In my view, Novo Nordisk's stock is attractive regardless of its recent shopping spree. Here's one reason. Its forward price-to-earnings (P/E) ratio is 19.6 at this writing, while the average for the healthcare industry is 16.2. Though that means Novo Nordisk is trading at a premium compared to its peers, its financial results justify that difference. In the first quarter, the company's net sales jumped 19% year over year to 78.1 billion Danish kroner ($12.1 billion), while its earnings per share rose by 15% to 6.53 DKK ($1). Revenue and earnings growth in that range is above what's considered "good" for a pharmaceutical company, especially one of this size. Perhaps Novo Nordisk was due for a sell-off -- its forward P/E looked extremely high a year ago. However, at current levels, shares now appear far more attractive, given the company's strong financial results. And when we take into account its pipeline and the recent deals it's made, Novo Nordisk looks even more promising -- the weight-management market is on an incredible growth path. Other than Eli Lilly, no company should seriously challenge Novo Nordisk anytime soon. In addition to its licensing deals, the Denmark-based drugmaker has promising, internally developed candidates. Novo Nordisk has just announced that it will start phase 3 studies for amycretin, an investigational weight loss product with both oral and subcutaneous formulations; this product delivered encouraging results in early-stage studies. Meanwhile, the company asked the U.S. Food and Drug Administration to approve an oral formulation of semaglutide (the active ingredient in Wegovy). In addition to its core area of expertise, Novo Nordisk has made a point of developing medicines in other fields, and has several promising candidates across various diseases. For all these reasons the stock looks like a buy at current levels, despite the challenges the company has faced in the past year. Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,821!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $886,880!* Now, it's worth noting Stock Advisor's total average return is 791% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Prosper Junior Bakiny has positions in Eli Lilly and Novo Nordisk. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy? was originally published by The Motley Fool
Wall Street Journal
an hour ago
- Wall Street Journal
Temu Battles TikTok-Like Backlash Over Data
When China-owned bargain site Temu last week entered into a data-storage deal with Oracle ORCL -1.38%decrease; red down pointing triangle, the move echoed TikTok's travails in trying to address U.S. data-privacy concerns. Temu, owned by Chinese e-commerce giant PDD Holdings PDD -0.25%decrease; red down pointing triangle, has in the last several years gained huge popularity among U.S. consumers with its ultracheap wares shipped from China. But it has also landed in the crosshairs of lawmakers who claim it inadequately protects U.S. consumers' data.
Android Authority
an hour ago
- Android Authority
If this OnePlus 15 camera leak is true, OnePlus might be making a critical mistake
Ryan Haines / Android Authority The OnePlus 13 is, without a doubt, one of my favorite Android phones available today — and for a multitude of reasons. Its design is great, performance is outstanding, and battery life is amazing. Unlike a lot of past OnePlus phones, the OnePlus 13's cameras are just as good (if not better) than the rest of its flagship competitors. And that's why the latest OnePlus 15 leak has me worried. Earlier this week, a well-known leaker teased a few details about the upcoming OnePlus 15, including the suggestion that the OnePlus 15 won't feature the Hasselblad camera partnership that has been on flagship OnePlus phones since the OnePlus 9 series. If true, it would mark a monumental change for OnePlus handsets — and it could ruin one of my favorite things about the OnePlus 13. Hasselblad is what makes OnePlus cameras special Joe Maring / Android Authority Out of everything the OnePlus 13 gets right (which is a pretty extensive list), its camera system is one of the main reasons I've used the phone so much this year. That's partly due to the excellent camera sensors, but more so because of the Hasselblad integration. OnePlus phones that utilize the Hasselblad partnership have a few camera tricks up their sleeve, but the most important thing is that they feature Hasselblad's unique color science and image tuning. And if you ask me, it's what makes OnePlus phones (particularly the OnePlus 13) so special. We're at a point with smartphone cameras where image/color tuning is one of the biggest differentiators between which phone camera you choose. That's not to say camera sensor technology has plateaued, but what a company does with said cameras is becoming increasingly more important. Ryan Haines / Android Authority For example, images captured with Google's Pixel phones have a distinct, flat appearance. There's often a lot of HDR post-processing that flattens shadows and reduces contrast. It's great if you want a super natural-looking photo, but they're often not very eye-catching. Samsung phones, meanwhile, often produce overly saturated and vibrant-looking pictures. It's not quite as aggressive today as it was a few years ago, but it's still there. OnePlus cameras also have their own distinct look to them, and it's arguably my favorite of any Android phone available today. The Hasselblad tuning on the OnePlus 13 delivers punchy colors without going overboard. It's not afraid to retain a lot of shadows and contrast in a way you'd never see from a Google Pixel phone. Photos aren't always 100% true-to-life, but they almost always have a striking, eye-catching aesthetic. I've included a few of my favorite examples above. I took all of these photos on the OnePlus 13, and each one stands out for different reasons. I love the warm, golden color the sun casts on the grass in the first picture, plus the shadows created by the numerous trees. I also adore the zoomed-in photo of the budding tree branch. Between the stark white flowers, the shadowy branch, and the saturated blue sky, it's a gorgeous pic. The image of my dog sitting in the sun, with a dark shadow cast across part of his face? My Pixel 9 could never. Joe Maring / Android Authority XPan OnePlus 13 photo And that's not to mention the Hasselblad-specific camera modes, my favorite being XPan Mode. I wrote an entire article about it earlier this year, but the gist is that it's one of the most unique camera modes available on Android today — and one of my favorite reasons to carry the OnePlus 13. I hope OnePlus knows what it's doing Ryan Haines / Android Authority If OnePlus doesn't renew its Hasselblad partnership for the OnePlus 15, what's going to replace it? Word on the street is that OnePlus will launch its own 'image brand' alongside its next flagship, meaning that OnePlus would be in charge of all its own color science and image tuning. Furthermore, Hasselblad camera modes such as XPan and Master Mode would likely be discontinued. Details on OnePlus's 'image brand' are still scarce, but if this is truly the route OnePlus has chosen, I hope the company knows what it's doing. Hasselblad's impact on OnePlus smartphones has been beyond significant, and the idea of it going away is worrisome. I'm feeling nervous about the OnePlus 15 in a way I wasn't previously. It's not that I don't trust OnePlus to create its own competent color tuning and camera modes, but when things are already working so well on the OnePlus 13, I don't like the idea of OnePlus throwing that all away and starting from scratch. It's also possible that OnePlus will be able to retain a lot of what it learned/designed during its time working with Hasselblad, and that this change (if it happens) won't have much impact. We'll ultimately have to wait and see how this shakes out, but from where we're sitting right now, I'm feeling nervous about the OnePlus 15 in a way I wasn't previously. OnePlus has something good with the OnePlus 13 camera, and I really, really hope it doesn't throw that away with the OnePlus 15.
